Inhibitor for viral replication
    2.
    发明授权
    Inhibitor for viral replication 失效
    抑制剂用于病毒复制

    公开(公告)号:US6153433A

    公开(公告)日:2000-11-28

    申请号:US849281

    申请日:1997-05-30

    摘要: A pharmaceutical agent which inhibits a replication of virus by increasing the specific enzymatic activity of liver and/or other tissue is offered.A viral replication inhibitor which contains N-acetyl-glucosaminyltransferase III (GnT-III) or gene thereof as an effective component. Examples of the gene are that which contains a sequence represented by SEQ ID NO:1 (length: 1,608) or by SEQ ID NO:2 (length: 1,593) in the Sequence List, that which is prepared by hybridization of it and codes for a polypeptide having a GnT-III activity or a functionally same activity and that in which the above is further integrated in vector.

    摘要翻译: PCT No.PCT / JP96 / 01986 Sec。 371日期1997年5月30日 102(e)日期1997年5月30日PCT提交1996年7月17日PCT公布。 公开号WO97 / 18836 日期1997年5月29日提供通过增加肝和/或其他组织的特异性酶活性来抑制病毒复制的药剂。 含有N-乙酰氨基葡糖基转移酶III(GnT-III)或其基因作为有效成分的病毒复制抑制剂。 该基因的实例包括序列表中SEQ ID NO:1(长度:1,608)或SEQ ID NO:2(长度:1,593)表示的序列,其通过杂交制备并编码 具有GnT-III活性或功能上相同的活性的多肽,其中上述进一步整合到载体中。

    Method for producing glycosylated indole compound and antibody against the compound
    5.
    发明授权
    Method for producing glycosylated indole compound and antibody against the compound 失效
    制备糖基化吲哚化合物和抗化合物抗体的方法

    公开(公告)号:US08124789B2

    公开(公告)日:2012-02-28

    申请号:US12329844

    申请日:2008-12-08

    CPC分类号: C07K16/44

    摘要: This invention provides a method of producing a large amount of an α-form or β-form of N-pyranosyl-tryptophan having a specified structure and preparing an antibody therefrom. The method comprises a step of allowing a pyranose compound to react with a 3-pyrazyl-indole compound in the presence of a first base to obtain a 1-pyranosyl-3-pyrazyl-indole compound, and a step of treating the 1-pyranosyl-3-pyrazyl-indole compound with an acid, treating the resultant with a hydrogenation catalyst, and further treating the resultant with a second base to synthesize N-pyranosyl-tryptophan, thereby producing an antibody therefrom.

    摘要翻译: 本发明提供一种生产具有特定结构并由其制备抗体的大量α-形式或“形式”的N-吡喃糖基 - 色氨酸的方法。 该方法包括使吡喃糖化合物与3-吡嗪基 - 吲哚化合物在第一碱的存在下反应得到1-吡喃糖基-3-吡嗪基 - 吲哚化合物的步骤,以及将1-吡喃糖基 -3-吡唑基 - 吲哚化合物与酸反应,用氢化催化剂处理所得物,并用第二碱处理所得产物以合成N-吡喃糖基 - 色氨酸,从而由此产生抗体。

    Vascular Aging-Predicting Factor and Utilization of the Same
    6.
    发明申请
    Vascular Aging-Predicting Factor and Utilization of the Same 审中-公开
    血管老化预测因子及其应用

    公开(公告)号:US20090136985A1

    公开(公告)日:2009-05-28

    申请号:US12085656

    申请日:2006-10-30

    IPC分类号: C12Q1/02 C07K7/06 C07K16/18

    摘要: Abstract A predicting factor for vascular aging and an examination method for an early-stage lesion resulting from vascular aging are provided. Specifically, a predicting factor for vascular aging comprising a human apolipoprotein B100 having a glutathionylated thiol group; a method of examining a lesion resulting from vascular aging contain measurement of a human apolipoprotein B100 having a glutathionylated thiol group in the blood sample; an antibody specifically recognizing an apolipoprotein B100 having a glutathionylated thiol group; a diagnostic agent or a diagnostic kit for an early-stage lesion resulting from vascular aging containing an antibody recognizing a human apolipoprotein B100 having a glutathionylated thiol group, are provided.

    摘要翻译: 摘要提供血管老化预后因素及血管老化引起的早期病变检查方法。 具体地说,包含具有谷胱甘肽化硫醇基的人载脂蛋白B100的血管老化的预测因子; 检查由血管衰老引起的病变的方法包括测定血液样品中具有谷胱甘肽化硫醇基的人载脂蛋白B100; 特异性识别具有谷胱甘肽化硫醇基的载脂蛋白B100的抗体; 提供了由含有识别具有谷胱甘肽化硫醇基团的人载脂蛋白B100的抗体的血管老化引起的早期病变的诊断试剂或诊断试剂盒。